Ann: ECQ Exercises Opitons to Acquire Cynata Inc , page-73

re: Ann: ECQ Exercises Opitons to Acquire Cyn...

Like mobile phones compete with PC's

Stem cells will compete with Pharmecuticals in the future.

There will be a huge need for 'off the shelf' stem cell products that can be produced on mass.

ECQ know this and can potentially make a lot of money from commercial manufacture for others to study.

One of the first aims of ECQ is a pilot study into commercial manufacture. They have already proven they can culture their unique cells on mass with early animal trials showing positve results.

As I have already mentioned, read MSB announcements around 2005. MSB has a market cap well north of 1 billion dollars.

As I understand, a person ( the first) was recently cured from aids using stem cell technology.

Stem cells are the future of medicne.

First movers will be rewarded.